Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
54 /100
HIGH RISK
Score updated Oct 13, 2026

SLDB — Solid Biosciences Inc. Dilution Risk Tracker

Track SLDB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SLDB — Get alerts when the score changes →

As of October 13, 2026, Solid Biosciences Inc. (SLDB) has a DilutionWatch DilutionScore of 54/100, rated HIGH dilution risk. Solid Biosciences Inc. has a market capitalization of $719.48M, 107.23M shares outstanding, 142 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $100.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 10%
💰 Capital Raise model 20%
• Active shelf registration ($100M, 14% of market cap)
🔔 Track SLDB — Get forecast alerts →

Market Data

Market Cap$719.48M
Shares Outstanding107.23M
Float53.74M
Cash$159.39M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore54/100DilutionWatch score record
Shares Outstanding107.23MVerified float table or market cache
Public Float53.74MVerified float table or market cache
Market Cap$719.48MMarket data cache
Cash Runway14.5 monthsDilutionWatch score inputs
Shelf Capacity$100.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 2, 8-K 1, S-3 2, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 40.2% shares (2026Q1 vs prior)
142 institutional holders · 118.89M shares
#1 PERCEPTIVE ADVISORS LLC 23.81M shares
#2 Bain Capital Life Sciences Investors, LLC 9.81M shares
#3 RA CAPITAL MANAGEMENT, L.P. 9.34M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.73M
Days to Cover7.7
% of Float23.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-19
S-3 SHELF 2026-03-19
S-3 SHELF 2026-03-19
4 INSIDER TRANSACTION 2026-03-11
8-K 8K EVENT 2026-03-06
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SLDB Dilution Snapshot

Solid Biosciences Inc. (SLDB) has a DilutionScore of 54/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SLDB's DilutionScore is currently 54/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 52/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202654/100HIGH53 days
Aug 14 – Aug 21, 202652/100HIGH7 days
Jul 17 – Aug 13, 202646/100MEDIUM28 days
Jul 16, 202645/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SLDB shares outstanding have increased 26.4% from 77.91M (Mar 2026) to 98.45M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202698.45M53.74M▼ 13.51%
May 17, 202698.45M62.13M▼ 2.97%
May 15, 202698.45M64.03M▲ 0.08%
May 08, 202698.41M63.98M▲ 3.06%
May 03, 202698.41M62.08M▲ 0.01%
Apr 21, 202698.39M62.07M▼ 1.55%
Mar 23, 202677.91M63.05M▲ 31.17%
Mar 22, 202677.91M48.07M▲ 16.62%
Mar 14, 202677.91M41.22M▼ 0.18%
Mar 12, 202677.91M41.29M▲ 8.99%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SLDB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SLDB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SLDB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SLDB
SLDB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.